# Osteogenic Action of a Medical Device Based on Beta-tricalcium Phosphate (BTCP)

> **NCT06935747** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Mario Pérez Sayáns** · enrollment: 30 (estimated)

## Conditions studied

- Bone Loss
- Regenerative Inflammation
- Third Molars Extraction

## Interventions

- **COMBINATION_PRODUCT:** Medical device: beta-tricalcium phosphate
- **OTHER:** Bovine Hydroxyapatite

## Key facts

- **NCT ID:** NCT06935747
- **Lead sponsor:** Mario Pérez Sayáns
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07
- **Primary completion:** 2026-03
- **Final completion:** 2026-07
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-04-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06935747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06935747, "Osteogenic Action of a Medical Device Based on Beta-tricalcium Phosphate (BTCP)". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT06935747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*